The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain
Open accessAbstract
Chronic inflammation is known to play an important role in the heterogeneous pathogenesis of Alzheimer's disease (AD). Activated astrocytes expressing glial fibrillary acidic protein (GFAP) are closely associated with AD pathology, such as tangles, neuritic plaques and amyloid depositions. Altogether, 46 soluble isoforms of GFAP were separated and most of them quantified by two-dimensional immunoblotting in frontal cortices of AD patients and age-matched controls. A 60% increase in the amount of more acidic isoforms of GFAP was observed in AD and these isoforms were both phosphorylated and N-glycosylated, while more basic isoforms were O-glycosylated and exhibited no quantitative differences between post-mortem AD and control brains. These data highlight the importance of exploring isoform-specific levels of proteins in pathophysiological conditions since modifications of proteins determine their activity state, localization, turnover and interaction with other molecules. Mechanisms, structures and functional consequences of modification of GFAP isoforms remain to be clarified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Proteomic analysis of post-translational modifications
Mann, M., & Jensen, O. N. (2003) · Nature Biotechnology · doi:10.1038/nbt0303-255 · Cited by 2,134
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803
Cited by
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Proteomic and oxidative stress analysis in human brain samples of Huntington disease
Sorolla, M. A., Reverter-Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.014 · Cited by 301
Venkateshappa, C., Harish, G., Mahadevan, A., Srinivas Bharath, M. M., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0755-8 · Cited by 232
Astrocytic dysfunction: Insights on the role in neurodegeneration
Rossi, D., & Volterra, A. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.012 · Cited by 219
Martínez, A., Portero‐Otin, M., Pamplona, R., & Ferrer, I. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00326.x · Cited by 213
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer’s Disease
Cioffi, F., Adam, R. H. I., & Broersen, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190863 · Cited by 204
Enteric GFAP expression and phosphorylation in Parkinson's disease
Clairembault, T., Kamphuis, W., Leclair‐Visonneau, L., Rolli‐Derkinderen, M., Coron, E., Neunlist, M., Hol, E. M., & Derkinderen, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12742 · Cited by 191
Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?
Fan, C.-K., Holland, C. V., Loxton, K., & Barghouth, U. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00106-14 · Cited by 185
Ferrer, I. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9243-5 · Cited by 172
Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
Stack, C., Jainuddin, S., Elipenahli, C., Gerges, M., Starkova, N., Starkov, A. A., Jové, M., Portero-Otin, M., Launay, N., Pujol, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu080 · Cited by 159
Kim, Y. E., Hwang, C. J., Lee, H. P., Kim, C. S., Son, D. J., Ham, Y. W., Hellström, M., Han, S.-B., Kim, H. S., Park, E. K., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.025 · Cited by 158
Biomarker discovery: A proteomic approach for brain cancer profiling
Khalil, A. A., & James, P. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2007.00374.x · Cited by 157
Torres-Platas, S. G., Nagy, C., Wakid, M., Turecki, G., & Mechawar, N. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.65 · Cited by 148
Moya‐Alvarado, G., Gershoni‐Emek, N., Perlson, E., & Bronfman, F. C. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r115.053330 · Cited by 139
Messing, A., & Brenner, M. (2020) · ASN NEURO · doi:10.1177/1759091420949680 · Cited by 139
The Neuroproteomics of Schizophrenia
English, J. A., Pennington, K., Dunn, M. J., & Cotter, D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.031 · Cited by 135
Domenico, F. D., Coccia, R., Cocciolo, A., Murphy, M. P., Cenini, G., Head, E., Butterfield, D. A., Giorgi, A., Schininà, M. E., Mancuso, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.013 · Cited by 135
Human astrocytes express aquaporin‐1 and aquaporin‐4 in vitro and in vivo
Satoh, J., Tabunoki, H., Yamamura, T., Arima, K., & Konno, H. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00774.x · Cited by 132
Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease
Petzold, A. (2014) · Brain Research · doi:10.1016/j.brainres.2014.12.027 · Cited by 131
Zussy, C., Brureau, A., Keller, E., Marchal, S., Blayo, C., Delair, B., IXART, G., Maurice, T., & Givalois, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053117 · Cited by 125
Jesse, S., Steinacker, P., Cepek, L., Arnim, C. A. F. V., Tumani, H., Lehnert, S., Kretzschmar, H. A., Baier, M., & Otto, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1075 · Cited by 119
Enteric glial cells: New players in Parkinson's disease?
Clairembault, T., Leclair‐Visonneau, L., Neunlist, M., & Derkinderen, P. (2015) · Movement Disorders · doi:10.1002/mds.25979 · Cited by 117
Time and space profiling of NMDA receptor co‐agonist functions
Mothet, J., Bail, M. L., & Billard, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13204 · Cited by 117
Nonenzymatic posttranslational protein modifications in ageing
Šoškić, V., Groebe, K., & Schrattenholz, A. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.12.001 · Cited by 111
Owen, J. B., Domenico, F. D., Sultana, R., Perluigi, M., Cini, C., Pierce, W. M. J., & Butterfield, D. A. (2008) · Journal of Proteome Research · doi:10.1021/pr800667a · Cited by 107
Proteomic research in psychiatry
Taurines, R., Dudley, E., Grassl, J., Warnke, A., Gerlach, M., Coogan, A. N., & Thome, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106931 · Cited by 100
Tura, A., Schuettauf, F., Monnier, P. P., Bartz‐Schmidt, K. U., & Henke‐Fahle, S. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1973 · Cited by 95
Miura, Y., & Endo, T. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.013 · Cited by 93
An update on clinical proteomics in Alzheimer’s research
Korolainen, M. A., Nyman, T. A., Aittokallio, T. A., & Pirttilä, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06558.x · Cited by 91
Self-citationMaarouf, C. L., Daugs, I. D., Kokjohn, T. A., Walker, D. G., Hunter, J. M., Kruchowsky, J., Woltjer, R. L., Kaye, J. A., Castaño, E. M., Sabbagh, M. N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027291 · Cited by 88
Park, Y., Nirajan, K. C., Paneque, A., & Cole, P. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126295 · Cited by 86
Crecelius, A. C., Götz, A., Arzberger, T., Fröhlich, T., Arnold, G. J., Ferrer, I., & Kretzschmar, H. A. (2008) · PROTEOMICS · doi:10.1002/pmic.200700728 · Cited by 82
Identification and characterization of GFAPκ, a novel glial fibrillary acidic protein isoform
Blechingberg, J., Holm, I. E., Nielsen, K. B., Jensen, T. H., Jørgensen, A. L., & Nielsen, A. L. (2007) · Glia · doi:10.1002/glia.20475 · Cited by 65
Herskowitz, J. H., Seyfried, N. T., Duong, D. M., Xia, Q., Rees, H. D., Gearing, M., Peng, J., Lah, J. J., & Levey, A. I. (2010) · Journal of Proteome Research · doi:10.1021/pr100666c · Cited by 80
Casta�o, E. M., Maarouf, C. L., Wu, T., Leal, M. C., Whiteside, C. M., Lue, L., Kokjohn, T. A., Sabbagh, M. N., Beach, T. G., & Roher, A. E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.001 · Cited by 69
Quantitative protein profiling of hippocampus during human aging
Xu, B., Gao, Y., Zhan, S., Xiong, F., Qiu, W., Qian, X., Wang, T., Wang, N., Zhang, D., Yang, Q., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.029 · Cited by 69
Ubiquitination and cysteine nitrosylation during aging and Alzheimer's disease
Riederer, I. M., Schiffrin, M., Kövari, E., Bouras, C., & Riederer, B. M. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.04.018 · Cited by 65
Elliott, J. L., Perng, M. D., Prescott, A. R., Jansen, K. A., Koenderink, G. H., & Quinlan, R. A. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0375 · Cited by 65
Zheng, J., & Bizzozero, O. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22488 · Cited by 62
Type III intermediate filaments as targets and effectors of electrophiles and oxidants
Viedma-Poyatos, Á., Pajares, M. A., & Pérez‐Sala, D. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101582 · Cited by 62
Sun, Y., Rong, X., Lu, W., Peng, Y., Jiang, L., Xu, S., Wang, L., & Wang, X. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142805 · Cited by 61
Insights into intermediate filament regulation from development to ageing
Hyder, C. L., Isoniemi, K. O., Torvaldson, E., & Eriksson, J. (2011) · Journal of Cell Science · doi:10.1242/jcs.041244 · Cited by 61
Benvenuti, L., D’Antongiovanni, V., Pellegrini, C., Antonioli, L., Bernardini, N., Blandizzi, C., & Fornai, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239199 · Cited by 60
Jin, P., Kim, J.-A., Choi, D.-Y., Lee, Y.-J., Jung, H. S., & Hong, J. T. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-2 · Cited by 59
Santpere, G., & Ferrer, I. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00173.x · Cited by 59
The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases
Gogishvili, D., Honey, M. I. J., Verberk, I. M. W., Vermunt, L., Hol, E. M., Teunissen, C. E., & Abeln, S. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16226 · Cited by 58
Protein oxidation in Huntington disease
Sorolla, M. A., Colman, M. J. R., Vall‐llaura, N., Tamarit, J., Ros, J., & Cabiscol, E. (2012) · BioFactors · doi:10.1002/biof.1013 · Cited by 58
Martínez, A., Carmona, M., Portero‐Otín, M., Naudí, A., Pamplona, R., & Ferrer, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e06f3 · Cited by 56
Muntané, G., Dalfó, E., Martínez, A., Rey, M. J., Ávila, J., Pérez, M., Portero‐Otín, M., Pamplona, R., Ayala, V., & Ferrer, I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04032.x · Cited by 56
Proteomics‐driven progress in neurodegeneration research
Fountoulakis, M., & Κοσσίδα, Σ. (2006) · Electrophoresis · doi:10.1002/elps.200500738 · Cited by 56
Katsipis, G., Tzekaki, E. E., Tsolaki, M., & Pantazaki, Α. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577744 · Cited by 54
Explorative and targeted neuroproteomics in Alzheimer's disease
Brinkmalm, A., Portelius, E., Öhrfelt, A., Brinkmalm, G., Andréasson, U., Gobom, J., Blennow, K., & Zetterberg, H. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.01.009 · Cited by 47
Weinreb, O., Driguès, N., Sagi, Y., Reznick, A. Z., Amit, T., & Youdim, M. B. H. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.169 · Cited by 47
Genade, T., & Lang, D. M. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.11.013 · Cited by 46
Housekeepers for accurate transcript expression analysis in Alzheimer's disease autopsy brain tissue
Gebhardt, F. M., Scott, H. A., & Dodd, P. R. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.11.002 · Cited by 45
Postsynaptic Proteome of Non-Demented Individuals with Alzheimer’s Disease Neuropathology
Zolochevska, O., Bjorklund, N., Woltjer, R., Wiktorowicz, J. E., & Taglialatela, G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180179 · Cited by 42
“GFAP can undergo many post-translational modifications, such as phosphorylation, sulfation, glycosylation, oxidation, acetylation and other [150].”
Phosphorylation of GFAP is Associated with Injury in the Neonatal Pig Hypoxic-Ischemic Brain
Sullivan, S. M., Sullivan, R., Miller, S. M., Ireland, Z., Bjorkman, S. T., Pow, D. V., & Colditz, P. B. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0774-5 · Cited by 41
Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims
Tannu, N. S., Mash, D. C., & Hemby, S. E. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001914 · Cited by 40
Neurochemical Profile of Dementia Pugilistica
Kokjohn, T. A., Maarouf, C. L., Daugs, I. D., Hunter, J. M., Whiteside, C. M., Malek-Ahmadi, M., Rodriguez, E., Kalback, W., Jacobson, S. A., Sabbagh, M. N., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2699 · Cited by 39
Serial protein labeling with infrared maleimide dyes to identify cysteine modifications
Riederer, I. M., Moreno-Herero, R., Leuba, G., & Riederer, B. M. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.04.006 · Cited by 39
Bandara, E. M. S., Asih, P. R., Pedrini, S., Hone, E., Fernando, W. M. A. D. B., & Martins, R. N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05219-3 · Cited by 38
Kumar, D., Sharma, A., & Sharma, L. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200203101828 · Cited by 38
The Role of Oxidative Stress in Neurodegenerative Diseases
Ksiazek-Winiarek, D. J., & Glabinski, A. R. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-0440-2_8 · Cited by 36
GFAPδ immunostaining improves visualization of normal and pathologic astrocytic heterogeneity
Andreiuolo, F. D. M., Junier, M., Hol, E. M., Miquel, C., Chimelli, L. M. C., Léonard, N., Chneiweiss, H., Daumas‐Duport, C., & Varlet, P. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2008.00936.x · Cited by 35
Gomez, A., & Ferrer, I. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0669-y · Cited by 35
Miyamae, Y., Han, J., Sasaki, K., Terakawa, M., Isoda, H., & Shigemori, H. (2011) · Cytotechnology · doi:10.1007/s10616-011-9341-1 · Cited by 32
“Recent studies show that several glycolytic enzymes (aldolase A, aldolase C, triose phosphate isomerase, phosphoglycerate kinase (PGK), and PGAM) are oxidatively damaged in advanced AD stages (Castegna et al. 2003; Korolainen et al. 2005; Korolainen et al. 2006; Reed et al. 2008; Sultana et al. 2006).”
BackgroundBlood biomarkers for dementia in Hispanic and non‐Hispanic White adults
Gonzales, M. M., Short, M. I., Satizábal, C. L., Bryant, S. O., Tracy, R. P., Zare, H., & Seshadri, S. S. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12164 · Cited by 31
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 30
Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease
Leuba, G., Vernay, A., Zimmermann, V., Saini, K., Kraftsik, R., & Savioz, A. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.009 · Cited by 28
Sukhorukova, E. G., Korzhevsky, D. E., & Alekseeva, O. S. (2015) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093015010019 · Cited by 28
Elhabak, M., Salama, A. A. A., & Salama, A. H. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122588 · Cited by 27
Abbas, H. A., Salama, A. M., El-Toumy, S. A. H., Salama, A., Tadros, S. H., & Gedaily, R. A. E. (2022) · Plants · doi:10.3390/plants11141792 · Cited by 27
Yang, Z., Arja, R. D., Zhu, T., Sarkis, G. A., Patterson, R. L., Romo, P., Rathore, D. S., Jaalouk, E., Weissman, A., Wong, A. T.-C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168960 · Cited by 27
Citrullination of glial intermediate filaments is an early response in retinal injury.
Wizeman, J. W., Nicholas, A. P., Ishigami, A., & Mohan, R. (2016) · PubMed Central · Cited by 27
Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patients
Hergenroeder, G. W., Moore, A. N., Schmitt, K. M., Redell, J. B., & Dash, P. K. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000502 · Cited by 23
Proteomic 2-D DIGE Profiling of APP23 Transgenic Mice Brain from Pre-plaque and Plaque Phenotypes
Guerreiro, N., Staufenbiel, M., & Gomez‐Mancilla, B. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13102 · Cited by 21
HNK-1 Carrier Glycoproteins Are Decreased in the Alzheimer’s Disease Brain
García‐Ayllón, M., Botella-López, A., Cuchillo‐Ibáñez, I., Rábano, A., Andreasen, N., Blennow, K., Ávila, J., & Sáez‐Valero, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9644-x · Cited by 20
Magnusson, K. R., & Brim, B. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00158-6 · Cited by 18
Exploring the Potential of Neuroproteomics in Alzheimer's Disease
Uddin, M. S., Kabir, M. T., Jakaria, M., Sobarzo‐Sánchez, E., Barreto, G. E., Perveen, A., Hafeez, A., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200603112030 · Cited by 17
Fonar, G., Polis, B., Sams, D. S., Levi, A., Malka, A., Bal, N. V., Maltsev, A. V., Elliott, E., & Samson, A. O. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02270-0 · Cited by 17
Guidolin, D., Zunarelli, E., Genedani, S., Trentini, G. P., Gaetani, C. D., Fuxé, K., Benegiamo, C., & Agnati, L. F. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.015 · Cited by 17
Zebrafish brain proteomics reveals central proteins involved in neurodegeneration
Gebriel, M., Prabhudesai, S. N., Uleberg, K., Larssen, E., Piston, D., Bjørnstad, A. H., & Møller, S. G. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23297 · Cited by 17
Sierri, G., Dal Magro, R., Vergani, B., Leone, B. E., Formicola, B., Taiarol, L., Fagioli, S., Kravicz, M., Tremolizzo, L., Calabresi, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010102 · Cited by 16
Proteomic approach to aging research
Sharov, V. S., & Schöneich, C. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.309 · Cited by 15
Squillario, M., & Barla, A. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-55 · Cited by 15
Cortelazzo, A., Felice, C. D., Guerranti, R., Signorini, C., Leoncini, S., Pecorelli, A., Scalabrì, F., Madonna, M., Filosa, S., Giovampaola, C. D., et al. (2015) · Neuroscience Research · doi:10.1016/j.neures.2015.10.002 · Cited by 14
Choi, J. Y., Hwang, C. J., Lee, D., Gu, S. M., Lee, H. P., Choi, D. Y., Oh, K. W., Han, S., & Hong, J. T. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8469-3 · Cited by 13
Proteomics and lipidomics in the human brain
Ferrer, I. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00020-7 · Cited by 13
Li, T., Vandesquille, M., Bay, S., Dhénain, M., Delatour, B., & Lafaye, P. J. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.001 · Cited by 13
Li, D., Wang, J., Yew, D. T., Lucy Forster, E., & Yao, Z. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.08.006 · Cited by 12
Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer’s Disease
Velásquez, E., Szeitz, B., Gil, J., Murillo, J. R., Palkovits, M., Renner, É., Hortobágyi, T., Döme, P., Nogueira, F. C. S., Marko‐Varga, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750665 · Cited by 12
Bamford, A. R., Parkin, G. M., Corey‐Bloom, J., & Thomas, E. A. (2025) · Journal of Neurology · doi:10.1007/s00415-024-12785-4 · Cited by 9
Zuo, Y., Lin, J., Zeng, X., Zou, Q., & Liu, X. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04134-3 · Cited by 9
Maadawi, Z. M. E. (2017) · International Journal of Stem Cells · doi:10.15283/ijsc16055 · Cited by 9
Khairallah, M. I., Kassem, L. A., Yassin, N. A. E., el Din, M. A. G., Zekri, M., & Attia, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.007 · Cited by 8
Proteomic Screen of Brain Glycoproteome Reveals Prion Specific Marker of Pathogenesis
Lamoureux, L., Simon, S. L. R., Waitt, B., & Knox, J. D. (2017) · PROTEOMICS · doi:10.1002/pmic.201700296 · Cited by 8
Gerstmann-Straüssler-Scheinker PRNP P102L-129V mutation
Ferrer, I., Carmona, M., Blanco, R., Recio, M., & Segundo, R. S. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0001-x · Cited by 8
Antibody Markers for Studying Neurodegeneration in the Nothobranchius Central Nervous System
Genade, T., & Lang, D. M. (2011) · Journal of Cytology & Histology · doi:10.4172/2157-7099.1000120 · Cited by 6
Metadata
- Authors
- Korolainen, M. A., Auriola, S., Nyman, T. A., Alafuzoff, I., & Pirttilä, T.
- Affiliations
- University of Eastern Finland (FI)
- Åbo Akademi University (FI)
- Corresponding author
- Korolainen, Minna A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 20
- Issue
- 3
- Pages
- 858-870
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2008337653
- Cited by
- 133
- References
- 104
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 9 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 7 · 2015: 12 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- cc-by-sa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- glial fibrillary acidic protein, Alzheimer's disease, protein phosphorylation, N-glycosylation, O-glycosylation, astrocytes, chronic inflammation, brain aging, frontal cortex, postmortem brain, protein modification
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Astrocytes, Brain, Encephalitis, Female, Glial Fibrillary Acidic Protein, Gliosis, Glycosylation, Humans, Male, Middle Aged, Phosphorylation, Protein Isoforms, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.